HTLV-1 is common in Japan, the Caribbean, and some areas of
Africa. Correspondingly, the associated myelopathy is more
prominent in these regions, compared to other areas of the
globe.
View page
Currently, there is no specific treatment regimen for HTLV-1
associated myelopathy. Steroid medications help lessen symptoms and
discomfort in many people.